Loading
·
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.